ANTI-FIBROTIC THERAPY MODULATES MORTALITY RISK ASSOCIATED WITH CIRCULATING PLASMA BIOMARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引:1
|
作者
Oldham, Justin
Alqalyoobi, Shehabaldin
Adegunsoye, Ayodeji
Linderholm, Angela
Hrusch, Cara
Pugashetti, Janelle
Boctor, Noelle
Sperling, Anne
Strek, Mary
Noth, Imre
机构
关键词
D O I
10.1016/j.chest.2019.08.305
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:258A / 259A
页数:2
相关论文
共 50 条
  • [1] Anti-Fibrotic Therapy Modulates Mortality Risk Associated with Circulating Plasma Biomarkers in Patients with Idiopathic Pulmonary Fibrosis
    Sarma, N.
    Adegunsoye, A. O.
    Alqalyoobi, S.
    Bowman, W. S.
    Lee, C.
    Pugashetti, J. V.
    Linderholm, A.
    Ma, S.
    Haczku, A.
    Strek, M. E.
    Noth, I.
    Oldham, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Anti-Fibrotic Therapy for Idiopathic Pulmonary Fibrosis Is Associated with Decreased Mortality Among Hospitalized Patients
    Kelly, B.
    Thao, V.
    Dempsey, T. M.
    Sangaralingham, L.
    Payne, S.
    Limper, A. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis
    Lopez-Lopez, Lidia
    Cesar, Eva Cabrera
    Lara, Estrella
    Juan, M. Victoria Hidalgo-San
    Parrado, Concepcion
    Martin-Montanez, Elisa
    Garcia-Fernandez, Maria
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (03): : 231 - 233
  • [4] Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
    Astor, Todd L. L.
    Goldberg, Hilary J. J.
    Snyder, Laurie D. D.
    Courtwright, Andrew
    Hachem, Ramsey
    Pena, Tahuanty
    Zaffiri, Lorenzo
    Criner, Gerard J. J.
    Budev, Marie M. M.
    Thaniyavarn, Tany
    Leonard, Thomas B. B.
    Bender, Shaun
    Barakat, Aliaa
    Breeze, Janis L. L.
    LaCamera, Peter
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [5] Anti-Fibrotic Therapy and Patient Reported Outcomes in Idiopathic Pulmonary Fibrosis
    Kay, S.
    White, E. S.
    Sheth, J. S.
    Flaherty, C.
    Getty, C.
    Holtze, C.
    Wang, B.
    Salisbury, M.
    Belloli, E.
    Flaherty, K. R.
    Murray, S.
    Xia, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Factors Affecting The Selection Of Anti-Fibrotic Therapy For Idiopathic Pulmonary Fibrosis
    Kaur, R.
    King, C.
    Brown, A.
    Ahmad, S.
    Shlobin, O. A.
    Weir, N.
    Nathan, S. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] Evaluation of Extracellular Matrix Biomarkers in Response to Anti-Fibrotic Treatment of Idiopathic Pulmonary Fibrosis
    Jessen, H.
    Hoyer, N.
    Ronnow, S.
    Karsdal, M.
    Leeming, D. J.
    Sand, J. M.
    Shaker, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
    Leuschner, Gabriela
    Stocker, Florian
    Veit, Tobias
    Kneidinger, Nikolaus
    Winter, Hauke
    Schramm, Rene
    Weig, Thomas
    Matthes, Sandhya
    Ceelen, Felix
    Arnold, Paola
    Munker, Dieter
    Klenner, Friederike
    Hatz, Rudolf
    Frankenberger, Marion
    Behr, Juergen
    Neurohr, Claus
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (02): : 268 - 274
  • [9] Real-World Tolerability Of Anti-Fibrotic Therapy For Idiopathic Pulmonary Fibrosis
    Kaur, R.
    King, C.
    Brown, A.
    Shlobin, O.
    Ahmad, S.
    Weir, N.
    Nathan, S. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
    Khor, Yet H.
    Ng, Yvonne
    Barnes, Hayley
    Goh, Nicole S. L.
    McDonald, Christine F.
    Holland, Anne E.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2020, 29 (157): : 1 - 16